Picture of Firebrick Pharma logo

FRE Firebrick Pharma Cashflow Statement

0.000.00%
au flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for Firebrick Pharma, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

2019
June 30th
2020
June 30th
2021
June 30th
2022
June 30th
2023
June 30th
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Changes in Working Capital-1.1-0.985-1.54-2.81-4.25
Other Operating Cash Flow
Cash from Operating Activities-1.06-0.985-1.94-4.2-5.78
Capital Expenditures-0.016-0.033-0.002
Purchase of Fixed Assets
Cash from Investing Activities-0.016-0.033-0.002
Financing Cash Flow Items0.5720.092-0.116-0.474-0.006
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities1.260.53.0110.20.997
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.195-0.4851.065.99-4.79